Company profile
Acenxion Biosystems company profile
Acenxion Biosystems is a privately funded medical device company that is developing rapid, gold standard, automated systems for phenotypic antimicrobial susceptibility testing (AST) and bacterial detection in blood cultures (Sepsis). Seamlessly fitting into current clinical workflows, Acenxion’s scalable fAST system(TM) reduces the time required for phenotypic testing to just 4-6 hours (versus 2 or more days), allowing clinicians rapid use of targeted precision treatment. Acenxion’s technology improves patient outcomes, reduces healthcare costs, and reduces the spread of antibiotic resistance, extending the useful life of antibiotics (Antibiotic Stewardship).
Business identity
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $0+
- Founded
- 2020-02-27
Headquarters
- Headquarters
- Cartersville, Georgia, United States
- Postal code
- 66047
- Country code
- US
- Continent
- North America